Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and tolerability of treatment for T-lymphoblastic lymphoma
(T-LBL) according to modified BFM-95 regimen for acute lymphoblastic leukemia.